Form4.ai tracks every SEC insider trade in real time. See every BOLT insider filing with a free account — no card.
See every BOLT insider filing — free account, no card.
Free accountBolt Biotherapeutics, Inc. (BOLT) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $133K. Most recent filing: Oct. 27, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 27, 2026 SEC filing | GUJRATHI SHEILA Chief Strategy Officer | Grant / award | — | — |
| Sep 21, 2026 SEC filing | Quinn William P. President, CEO and CFO | Sold | $55,933 | — |
| Sep 21, 2026 SEC filing | Nemec Sarah Senior VP, Finance and PAO | Sold | $24,099 | — |
Create a free account to see all 4 BOLT filings from the last 90 days. No card needed.
Create free accountWant BOLT insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.